Bailard’s Exact Sciences EXAS Stock Holding History

Bailard’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,503	Closed	-$239K	–	745
2023 Q3	$239K	Buy	+3,503	New	+$297K	0.01%	608
2023 Q2	–	Sell	-3,092	Closed	-$210K	–	716
2023 Q1	$210K	Buy	+3,092	New	+$199K	0.01%	638
2022 Q2	–	Sell	-14,557	Closed	-$1.02M	–	718
2022 Q1	$1.02M	Sell	14,557 -340	-2%	-$24.9K	0.03%	261
2021 Q4	$1.16M	Hold	14,897	–	–	0.04%	249
2021 Q3	$1.42M	Hold	14,897	–	–	0.05%	228
2021 Q2	$1.85M	Sell	14,897 -664	-4%	-$79.2K	0.06%	210
2021 Q1	$2.05M	Buy	15,561 +12,469	+403%	+$1.71M	0.08%	197
2020 Q4	$410K	Hold	3,092	–	–	0.02%	368
2020 Q3	$315K	Hold	3,092	–	–	0.02%	377
2020 Q2	$269K	Buy	+3,092	New	+$247K	0.02%	379
2020 Q1	–	Sell	-3,092	Closed	-$286K	–	491
2019 Q4	$286K	Sell	3,092 -1,108	-26%	-$97.4K	0.02%	420
2019 Q3	$380K	Hold	4,200	–	–	0.02%	346
2019 Q2	$496K	Hold	4,200	–	–	0.03%	285
2019 Q1	$364K	Hold	4,200	–	–	0.02%	374
2018 Q4	$265K	Hold	4,200	–	–	0.02%	438
2018 Q3	$331K	Buy	+4,200	New	+$274K	0.02%	451

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bailard's EXAS Position: Q4 2023 in Review

Bailard sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 3,503 shares — an estimated $239K sold.

Bailard first reported a position in EXAS in Q3 2018 and held it in 16 quarters. The position peaked at $2.05M in Q1 2021. 646 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

Bailard reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
Bailard sold 3,503 Exact Sciences shares in Q4 2023, an estimated $239K.
Bailard first reported a position in Exact Sciences in Q3 2018 and held it in 16 quarters.
Bailard's Exact Sciences position peaked at $2.05M in Q1 2021.
646 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Bailard's 13F filing for Q4 2023, filed 2 Feb 2024.